Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Proteo completes patient recruitment in phase II Elafin trial

April 27, 2010

CHMP recommends conditional marketing approval for Votrient

April 27, 2010

Oncolytics Biotech completes phase I enrollment for phase I/II Reolysin trial

April 27, 2010

Temozolomide shows activity in pituitary tumors and carcinomas

April 27, 2010

Telik presents novel Aurora A/B and VEGFR-2 inhibitors

April 27, 2010

EMD-1214063 displays potent and selective c-Met inhibition

April 27, 2010

Pfizer halts phase III trial of Sutent in liver cancer

April 26, 2010

Aragon secures financing to advance ARN-509

April 26, 2010

Genentech submits supplemental BLA to FDA for Herceptin in stomach cancer

April 26, 2010

Celtic Pharma evaluates Xerecept in pediatric patients with metastatic brain tumors

April 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...